Prescription charges scrapped in Northern Ireland and cut to 3 in Scotland

6 April 2010

Prescription charges were abolished on Thursday in Northern Ireland and cut to £3 ($4.47) in Scotland. However, UK Health Minister Mike O'Brian announced last week, charges in England have remained at £7.20 for 2010/11 with no changes to age-exemption criteria, health minister UK Mike O'Brien announced last week.

Northern Ireland Health Minister Michael McGimpsey said the introduction of free scrips was the end of 'a tax on illness,' adding that 'charging people for vital medication is totally against the principles of a health service that is free at the point of use.' The cost of abolishing prescription charges would be accommodated from within the existing health budget and no existing services would be affected by this decision, he added.

Rx Coalition calls for similar action in England

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical